Skip to main content

International Journal of Hematology

Ausgabe 4/2020

Inhalt (21 Artikel)

Images in Hematology

18FDG-PET imaging and histopathology in neuroleukemiosis with acute myeloid leukemia

Yusuke Kiyoki, Ryota Matsuoka, Tomohiro Kaneta, Hidekazu Nishikii

Rapid Communication

Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry

Aya Nakaya, Takae Kohara, Hirohiko Shibayama, Yoshiyuki Onda, Junya Kanda, Hitomi Kaneko, Kazunori Imada, Toru Kida, Satoru Kosugi, Jun Ishikawa, Ryosuke Yamamura, Yutaka Shimazu, Hirokazu Tanaka, Shin-ichi Fuchida, Yuji Shimura, Miki Kiyota, Katsuya Wada, Tomoki Ito, Nobuhiko Uoshima, Hideo Yagi, Satoshi Yoshihara, Kensuke Ohta, Chihiro Shimazaki, Masayuki Hino, Akifumi Takaori-Kondo, Junya Kuroda, Itaru Matsumura, Yuzuru Kanakura, Shosaku Nomura

Review Article

Cutaneous manifestations of B-cell chronic lymphocytic leukemia

Elena A. Morozova, Olga Yu. Olisova, Eugene A. Nikitin

Original Article

Results from multinational phase 3 studies of ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: subgroup analysis of Japanese patients

Ken Ishiyama, Shinji Nakao, Kensuke Usuki, Yuji Yonemura, Takayuki Ikezoe, Michihiro Uchiyama, Yasuo Mori, Tetsuya Fukuda, Masaya Okada, Shin-ichiro Fujiwara, Hideyoshi Noji, Scott Rottinghaus, Rasha Aguzzi, Jun Yokosawa, Jun-Ichi Nishimura, Yuzuru Kanakura, Shinichiro Okamoto

Original Article

New insights on patient-related risk factors for venous thromboembolism in patients with solid organ cancers

Aditya Kotecha, Deepa Raghavan, Sumeet K. Yadav, Anupam A. Sule, Camelia Arsene

Original Article

Acute myeloid leukemia during pregnancy: a single institutional experience with 17 patients and literature review

Yi-Wei Li, Yang-Feng Xu, Wei Hu, Shen-Xian Qian, Can Chen

Original Article

Development of anti-human CADM1 monoclonal antibodies as a potential therapy for adult T-cell leukemia/lymphoma

Syahrul Chilmi, Shingo Nakahata, Yanuar Rahmat Fauzi, Tomonaga Ichikawa, Chikako Tani, Mathurot Suwanruengsri, Ryoji Yamaguchi, Tadashi Matsuura, Gene Kurosawa, Kazuhiro Morishita

Original Article

Phase I study of duvelisib in Japanese patients with relapsed or refractory lymphoma

Koji Izutsu, Koji Kato, Hitoshi Kiyoi, Go Yamamoto, Kazuyuki Shimada, Koichi Akashi

Original Article

Myeloablative intravenous busulfan-containing regimens for allo-HSCT in AML or MDS patients over 54 years old: combined results of three phase II studies

Naoyuki Uchida, Kana Matsumoto, Toru Sakura, Michihiro Hidaka, Toshihiro Miyamoto, Tetsuya Eto, Yoshinobu Maeda, Tohru Murayama, Naohito Fujishima, Goichi Yoshimoto, Kunihiko Morita, Junji Kishimoto, Takanori Teshima, Shuichi Taniguchi, Takuya Yamashita, Shin-ichiro Mori, Koichi Akashi, Mine Harada

Original Article

Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group

Sachie Kasai, Hidehiro Itonaga, Daisuke Niino, Hiroaki Miyoshi, Takeharu Kato, Daisuke Imanishi, Machiko Fujioka, Takafumi Furumoto, Shinya Sato, Yasushi Sawayama, Jun Taguchi, Yoshitaka Imaizumi, Tomoko Hata, Shinichiro Yoshida, Yukiyoshi Moriuchi, Koichi Ohshima, Yasushi Miyazaki

Original Article

Differences among hemoglobin thresholds for red blood cell transfusions in patients with hematological diseases in teaching hospitals: a real world data in Japan

Akihiko Yokohama, Yoshiki Okuyama, Yasunori Ueda, Masumi Itoh, Shin-ichiro Fujiwara, Yuichi Hasegawa, Kazuhiro Nagai, Kimika Arakawa, Koji Miyazaki, Masanori Makita, Mai Watanabe, Kazuhiko Ikeda, Asashi Tanaka, Keizo Fujino, Mayumi Matsumoto, Shigeyoshi Makino, Shuichi Kino, Akihiro Takeshita, Kazuo Muroi

Original Article

Potential role of Howell−Jolly bodies in identifying functional hyposplenism: a prospective single-institute study

Yuya Nakagami, Kaori Uchino, Hiroaki Okada, Kojiro Suzuki, Megumi Enomoto, Shohei Mizuno, Hidesuke Yamamoto, Ichiro Hanamura, Takayuki Nakayama, Hiroya Tani, Akiyoshi Takami

Zur Zeit gratis COVID-19 Original Article

Changes of hematological and immunological parameters in COVID-19 patients

Xiaohong Yuan, Wanling Huang, Bing Ye, Cunrong Chen, Rongfeng Huang, Feng Wu, Qin Wei, Wei Zhang, Jianda Hu

Original Article

Analysis of the BRAF and MAP2K1 mutations in patients with Langerhans cell histiocytosis in Japan

Tomomi Hayase, Shiori Saito, Yoko Shioda, Toshihiko Imamura, Kenichiro Watanabe, Kentaro Ohki, Takako Yoshioka, Yukiko Oh, Yuta Kawahara, Hitomi Niijima, Shinsaku Imashuku, Akira Morimoto

Original Article

Short-term effectiveness of ruxolitinib in the treatment of recurrent or refractory hemophagocytic lymphohistiocytosis in children

Ang Wei, Honghao Ma, Zhigang Li, Liping Zhang, Qing Zhang, Dong Wang, Hongyun Lian, Rui Zhang, Tianyou Wang

Original Article

Nausea and vomiting during post-transplantation cyclophosphamide administration

Toshihisa Nakashima, Yoshihiro Inamoto, Ayumu Ito, Takashi Tanaka, Sung-Won Kim, Takahiro Fukuda, Yoshinori Makino, Hironobu Hashimoto, Masakazu Yamaguchi

Case Report

Extranasal extranodal NK/T-cell lymphoma associated with systemic lupus erythematosus

Satoshi Ichikawa, Noriko Fukuhara, Tsuyoshi Shirai, Tomonori Ishii, Ryo Ichinohasama, Hideo Harigae

Letter to the Editor

Complete metabolic remission in an 84-year old patient with relapsed/refractory diffuse large B-cell lymphoma following combination immunotherapy with lenalidomide plus rituximab

Ciprian Tomuleasa, Sabina Iluta, Sergiu Pasca, Andrei Roman, Doina Piciu, Ciprian Jitaru, Patric Teodorescu, Ioana Rus, Anca Bojan, Delia Dima, Mihnea Zdrenghea, Bobe Petrushev

Correction

Correction to: Menatetrenone facilitates hematopoietic cell generation in a manner that is dependent on human bone marrow mesenchymal stromal/stem cells

Aya Fujishiro, Masaki Iwasa, Sumie Fujii, Taira Maekawa, Akira Andoh, Kaoru Tohyama, Akifumi Takaori-Kondo, Yasuo Miura

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.